Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8273571rdf:typepubmed:Citationlld:pubmed
pubmed-article:8273571lifeskim:mentionsumls-concept:C0175677lld:lifeskim
pubmed-article:8273571lifeskim:mentionsumls-concept:C0020155lld:lifeskim
pubmed-article:8273571lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:8273571lifeskim:mentionsumls-concept:C0026724lld:lifeskim
pubmed-article:8273571lifeskim:mentionsumls-concept:C1704242lld:lifeskim
pubmed-article:8273571lifeskim:mentionsumls-concept:C0033554lld:lifeskim
pubmed-article:8273571lifeskim:mentionsumls-concept:C0003211lld:lifeskim
pubmed-article:8273571lifeskim:mentionsumls-concept:C0683150lld:lifeskim
pubmed-article:8273571lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:8273571lifeskim:mentionsumls-concept:C0445223lld:lifeskim
pubmed-article:8273571lifeskim:mentionsumls-concept:C1552599lld:lifeskim
pubmed-article:8273571lifeskim:mentionsumls-concept:C1704787lld:lifeskim
pubmed-article:8273571lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:8273571pubmed:dateCreated1994-1-31lld:pubmed
pubmed-article:8273571pubmed:abstractTextThe relationship between endoscopically observed gastric mucosal damage, elicited following repeated oral intake for 7 d of four NSAIDs, to their effects on antral and fundic production of PGE2, 6-keto-PGF1 alpha and TxB2 (assayed by GC-MS), mucosal histology and plasma concentration profiles was studied in 40 normal males. Subjects received azapropazone (APZ) 600 mg b.i.d., indomethacin (IND) 50 mg t.i.d., naproxen (NAP) 500 mg b.i.d., piroxicam (PIR) 20 mg qq.d., or one placebo capsule t.i.d. (N = 8/group). Plasma NSAIDs (HPLC) levelled at 7 d. Mucosal damage occurred in the antrum region with IND and NAP. APZ and PIR exhibited no differences compared to placebo. NAP and IND reduced all three prostanoids in the antrum while APZ and PIR were ineffective. Fundic PGE2 was reduced by IND, NAP and PIR; APZ had no effects. Thus, mucosal damage relates to effects on prostanoid production in the antrum but not in the fundus.lld:pubmed
pubmed-article:8273571pubmed:languageenglld:pubmed
pubmed-article:8273571pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8273571pubmed:citationSubsetIMlld:pubmed
pubmed-article:8273571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8273571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8273571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8273571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8273571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8273571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8273571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8273571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8273571pubmed:statusMEDLINElld:pubmed
pubmed-article:8273571pubmed:issn0065-4299lld:pubmed
pubmed-article:8273571pubmed:authorpubmed-author:RainsfordK...lld:pubmed
pubmed-article:8273571pubmed:authorpubmed-author:HuntR HRHlld:pubmed
pubmed-article:8273571pubmed:authorpubmed-author:JamesCClld:pubmed
pubmed-article:8273571pubmed:authorpubmed-author:JohnsonD MDMlld:pubmed
pubmed-article:8273571pubmed:authorpubmed-author:HillR ERElld:pubmed
pubmed-article:8273571pubmed:authorpubmed-author:SalenaB JBJlld:pubmed
pubmed-article:8273571pubmed:authorpubmed-author:StetskoP IPIlld:pubmed
pubmed-article:8273571pubmed:issnTypePrintlld:pubmed
pubmed-article:8273571pubmed:volume39 Spec Nolld:pubmed
pubmed-article:8273571pubmed:ownerNLMlld:pubmed
pubmed-article:8273571pubmed:authorsCompleteYlld:pubmed
pubmed-article:8273571pubmed:paginationC21-3lld:pubmed
pubmed-article:8273571pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8273571pubmed:meshHeadingpubmed-meshheading:8273571-...lld:pubmed
pubmed-article:8273571pubmed:meshHeadingpubmed-meshheading:8273571-...lld:pubmed
pubmed-article:8273571pubmed:meshHeadingpubmed-meshheading:8273571-...lld:pubmed
pubmed-article:8273571pubmed:meshHeadingpubmed-meshheading:8273571-...lld:pubmed
pubmed-article:8273571pubmed:meshHeadingpubmed-meshheading:8273571-...lld:pubmed
pubmed-article:8273571pubmed:meshHeadingpubmed-meshheading:8273571-...lld:pubmed
pubmed-article:8273571pubmed:meshHeadingpubmed-meshheading:8273571-...lld:pubmed
pubmed-article:8273571pubmed:meshHeadingpubmed-meshheading:8273571-...lld:pubmed
pubmed-article:8273571pubmed:meshHeadingpubmed-meshheading:8273571-...lld:pubmed
pubmed-article:8273571pubmed:meshHeadingpubmed-meshheading:8273571-...lld:pubmed
pubmed-article:8273571pubmed:meshHeadingpubmed-meshheading:8273571-...lld:pubmed
pubmed-article:8273571pubmed:meshHeadingpubmed-meshheading:8273571-...lld:pubmed
pubmed-article:8273571pubmed:meshHeadingpubmed-meshheading:8273571-...lld:pubmed
pubmed-article:8273571pubmed:meshHeadingpubmed-meshheading:8273571-...lld:pubmed
pubmed-article:8273571pubmed:year1993lld:pubmed
pubmed-article:8273571pubmed:articleTitleEffects of chronic NSAIDs on gastric mucosal injury related to mucosal prostanoids, and plasma drug concentrations in human volunteers.lld:pubmed
pubmed-article:8273571pubmed:affiliationDepartment of Biomedical Sciences, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada.lld:pubmed
pubmed-article:8273571pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8273571pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8273571pubmed:publicationTypeRandomized Controlled Triallld:pubmed